Cargando…
The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury
OBJECTIVES: To verify the protective effect of phosphocreatine on myocardium in an ischemic model and the possible mechanism of action. METHODS: The model of myocardial ischemia/reperfusion (I/R) was established by the ligation balloon method. 30 SD rats were randomly divided into three groups, n = ...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847337/ https://www.ncbi.nlm.nih.gov/pubmed/33552599 http://dx.doi.org/10.1155/2021/8838151 |
_version_ | 1783644911528050688 |
---|---|
author | Wang, Chen-xi Guo, Jun-jun Di, An-jie Zhu, Yu Han, Wei-min Cheng, An-ran Li, Cheng Si, Rui-chan Lan, Tian-shu Zhang, Ran Liu, Hong-li Yan, Guo-liang |
author_facet | Wang, Chen-xi Guo, Jun-jun Di, An-jie Zhu, Yu Han, Wei-min Cheng, An-ran Li, Cheng Si, Rui-chan Lan, Tian-shu Zhang, Ran Liu, Hong-li Yan, Guo-liang |
author_sort | Wang, Chen-xi |
collection | PubMed |
description | OBJECTIVES: To verify the protective effect of phosphocreatine on myocardium in an ischemic model and the possible mechanism of action. METHODS: The model of myocardial ischemia/reperfusion (I/R) was established by the ligation balloon method. 30 SD rats were randomly divided into three groups, n = 10 in each group. Sham operation group: the coronary artery was not blocked and observed for 120 minutes. The ischemia/reperfusion (I/R) group was given ischemia for 30 minutes and ischemia reperfusion for 90 minutes. Phosphocreatine (PCr) group: after 30 minutes of ischemia, the rats were intraperitoneally injected with PCr (200 mg/kg) for 90 minutes. The animal groups of myocardial ischemia/reperfusion model in vitro were the same as those in vivo. The heart was removed by thoracotomy and washed immediately in H-K buffer solution. Then, the heart was installed on the Langendorff instrument. The concentration of PCr perfusion fluid in the PCr group was 10 mmol/L. The changes in coronary blood flow in isolated myocardium were recorded. The heart rate and electrocardiogram were recorded by RM6240BT. At the end of the experiment, myocardial pathological sections and Cx43 immunofluorescence staining were made, and the contents of malondialdehyde (MDA) in myocardial tissue were detected. RESULTS: Phosphocreatinine treatment improved the myocardial ischemia model, performance in electrocardiogram (ECG) changes (ST segment apparent), and histological changes (decrease in necrotic myocardial cells, inflammatory cell infiltration, and a reduction in myocardial edema). At the same time, MDA decreased, while coronary blood flow and Cx43 expression significantly improved. CONCLUSIONS: Phosphocreatine can improve the electrocardiogram and restore histologic changes in ischemic myocardium and coronary blood flow. The postulated mechanism is by inhibiting the generation of free oxygen radicals and restoring the expression of Cx43 protein. |
format | Online Article Text |
id | pubmed-7847337 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-78473372021-02-04 The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury Wang, Chen-xi Guo, Jun-jun Di, An-jie Zhu, Yu Han, Wei-min Cheng, An-ran Li, Cheng Si, Rui-chan Lan, Tian-shu Zhang, Ran Liu, Hong-li Yan, Guo-liang Cardiol Res Pract Research Article OBJECTIVES: To verify the protective effect of phosphocreatine on myocardium in an ischemic model and the possible mechanism of action. METHODS: The model of myocardial ischemia/reperfusion (I/R) was established by the ligation balloon method. 30 SD rats were randomly divided into three groups, n = 10 in each group. Sham operation group: the coronary artery was not blocked and observed for 120 minutes. The ischemia/reperfusion (I/R) group was given ischemia for 30 minutes and ischemia reperfusion for 90 minutes. Phosphocreatine (PCr) group: after 30 minutes of ischemia, the rats were intraperitoneally injected with PCr (200 mg/kg) for 90 minutes. The animal groups of myocardial ischemia/reperfusion model in vitro were the same as those in vivo. The heart was removed by thoracotomy and washed immediately in H-K buffer solution. Then, the heart was installed on the Langendorff instrument. The concentration of PCr perfusion fluid in the PCr group was 10 mmol/L. The changes in coronary blood flow in isolated myocardium were recorded. The heart rate and electrocardiogram were recorded by RM6240BT. At the end of the experiment, myocardial pathological sections and Cx43 immunofluorescence staining were made, and the contents of malondialdehyde (MDA) in myocardial tissue were detected. RESULTS: Phosphocreatinine treatment improved the myocardial ischemia model, performance in electrocardiogram (ECG) changes (ST segment apparent), and histological changes (decrease in necrotic myocardial cells, inflammatory cell infiltration, and a reduction in myocardial edema). At the same time, MDA decreased, while coronary blood flow and Cx43 expression significantly improved. CONCLUSIONS: Phosphocreatine can improve the electrocardiogram and restore histologic changes in ischemic myocardium and coronary blood flow. The postulated mechanism is by inhibiting the generation of free oxygen radicals and restoring the expression of Cx43 protein. Hindawi 2021-01-22 /pmc/articles/PMC7847337/ /pubmed/33552599 http://dx.doi.org/10.1155/2021/8838151 Text en Copyright © 2021 Chen-xi Wang et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wang, Chen-xi Guo, Jun-jun Di, An-jie Zhu, Yu Han, Wei-min Cheng, An-ran Li, Cheng Si, Rui-chan Lan, Tian-shu Zhang, Ran Liu, Hong-li Yan, Guo-liang The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury |
title | The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury |
title_full | The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury |
title_fullStr | The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury |
title_full_unstemmed | The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury |
title_short | The Protective Effect of Cx43 Protein-Mediated Phosphocreatine on Myocardial Ischemia/Reperfusion Injury |
title_sort | protective effect of cx43 protein-mediated phosphocreatine on myocardial ischemia/reperfusion injury |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847337/ https://www.ncbi.nlm.nih.gov/pubmed/33552599 http://dx.doi.org/10.1155/2021/8838151 |
work_keys_str_mv | AT wangchenxi theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT guojunjun theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT dianjie theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT zhuyu theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT hanweimin theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT chenganran theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT licheng theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT siruichan theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT lantianshu theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT zhangran theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT liuhongli theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT yanguoliang theprotectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT wangchenxi protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT guojunjun protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT dianjie protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT zhuyu protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT hanweimin protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT chenganran protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT licheng protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT siruichan protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT lantianshu protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT zhangran protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT liuhongli protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury AT yanguoliang protectiveeffectofcx43proteinmediatedphosphocreatineonmyocardialischemiareperfusioninjury |